scispace - formally typeset
S

Stephan Bohlhalter

Researcher at University of Bern

Publications -  107
Citations -  3248

Stephan Bohlhalter is an academic researcher from University of Bern. The author has contributed to research in topics: Apraxia & Schizophrenia. The author has an hindex of 27, co-authored 100 publications receiving 2534 citations. Previous affiliations of Stephan Bohlhalter include National Institutes of Health & University Hospital of Bern.

Papers
More filters
Journal ArticleDOI

Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study.

TL;DR: The results of this study indicate that paralimbic and sensory association areas are critically implicated in tic generation, similar to movements triggered internally by unpleasant sensations, as has been shown for pain or itching.
Journal ArticleDOI

Theta burst stimulation reduces disability during the activities of daily living in spatial neglect

TL;DR: Investigation of whether the repeated application of continuous theta burst stimulation trains could ameliorate spatial neglect on a quantitative measure of the activities of daily living during spontaneous behaviour found it to be a viable add-on therapy in neglect rehabilitation that facilitates recovery of normal everyday behaviour.
Journal ArticleDOI

The role of the dorsal stream for gesture production.

TL;DR: Results demonstrate that not only PPc but also the PMv acts in the processing of sensorimotor information during gestures, which might be the substrate underlying selective deficits in ideomotor apraxia patients.
Journal ArticleDOI

Comprehensive assessment of gesture production: a new test of upper limb apraxia (TULIA).

TL;DR: Evaluated the reliability and validity of a newly developed test of upper limb apraxia (TULIA), which is comprehensive and still short to administer.
Journal ArticleDOI

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Angelo Antonini, +78 more
TL;DR: LCIG treatment led to sustained improvements in motor fluctuations, non-motor symptoms particularly sleep/fatigue, mood/cognition and gastrointestinal domains, as well as quality of life in advanced PD patients over 24 months.